TEAD Inhibitor

Advertisement

cGxPJobs Banner

Orion Pharma Presents First ODM-212 Cancer Trial Data at ASCO 2026

ESPOO, Finland, May 21, 2026 Orion Pharma announced that it will present the first clinical data from its ongoing...

By cGxPwire Editor
May 22, 2026

Read More

.Clinical Bio-Pharma

Vivace Therapeutics Gains FDA Fast Track Designation for VT3989 in Mesothelioma

SAN MATEO, Calif., October 8, 2025 — Vivace Therapeutics, Inc., a biotechnology company pioneering small molecule cancer therapies that...

By cGxPwire Editor
October 8, 2025

Read More

Advertisement

cGxPJobs

Directory